Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Bioasis (Details) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Jun. 20, 2023 |
Nov. 02, 2020 |
Feb. 25, 2019 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Agreements | |||||
| Acquisition of royalty and commercial payment receivables | $ 45,000,000 | ||||
| Contingent consideration under RPAs, AAAs, and CPPAs | 3,000,000 | $ 7,000,000 | |||
| Payments of consideration under RPAs, AAAs and CPPAs | 53,000,000 | 14,650,000 | |||
| Credit losses on purchased receivables | $ 30,904,000 | 1,575,000 | |||
| Bioasis | Royalty Purchase Agreement | |||||
| Agreements | |||||
| Acquisition of royalty and commercial payment receivables | $ 1,200,000 | $ 400,000 | |||
| Contingent consideration under RPAs, AAAs, and CPPAs | $ 75,000 | $ 0 | |||
| Payments of consideration under RPAs, AAAs and CPPAs | $ 1,200,000 | ||||
| Credit losses on purchased receivables | $ 1,600,000 | ||||
| Write off of allowance for credit losses | $ 1,600,000 | ||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Liability recorded for contingent consideration under purchase agreements. May include royalty purchase agreements, assignment and assumption agreements, and commercial payment purchase agreements. Includes contingent consideration recognized under ASC 815 and measured at fair value as a current liability at the inception of the transaction. Also includes contingent consideration recognized under ASC 450 if it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Classified as current. No definition available.
|
| X | ||||||||||
- Definition Amount of credit loss on purchased receivables relating to royalty and license purchase agreements. No definition available.
|
| X | ||||||||||
- Definition Amount of cash outflow for consideration under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), Commercial payment purchase agreement (CPPAs) and other agreements classified as investing activities. Payments may include upfront payments, one-time payments, milestone payments and contingent consideration payments. No definition available.
|
| X | ||||||||||
- Definition Amount of writeoff of right to consideration from purchased receivables, charged against allowance for credit loss. No definition available.
|
| X | ||||||||||
- Definition Increase in rights receivable due to acquisition of royalty and commercial payment receivables under the cost recovery method. Includes both current and noncurrent rights receivable. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|